|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
| Address1 | 601 13th St., NW |
Address2 |
|
| City | Washington |
State | DC |
Zip Code | 20005-2000 |
Country | USA |
3. Principal place of business (if different than line 2)
| City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 46676-12
|
||||||||
|
6. House ID# 395790000
|
||||||||
| TYPE OF REPORT | 8. Year | 2020 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
| 10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
| INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| 12. Lobbying | 13. Organizations | ||||||||
| INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
| Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
|
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
|||||||||
| Signature | Digitally Signed By: AMY E. MODLIN |
Date | 4/20/2020 7:15:09 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
Affordable Care Act (ACA), Affordability, ACA Regulations; ACA Stabilization; Health Reform, Risk Adjustment; opioids; Marketplace stability; Individual Market Reform; Health Care Costs; Mental Health; Small Business Plans, CRSs; SNPs; 42 CFR Part 2; Transparency; Silverloading; Health IT; Surprise billing; Transparency; Small Business; State Felxibility; Education and Enrollment; Prior Authorization; All payer claims database; Negotiated rate disclosure; Consumer facing App, disclosures; Provider directories; Medicare for All, Medicare Buy-in; Maternal Health; Senior's health care; Community Health NBPP (Notice Benefit and Payment Parameters); COVID-19 Response/Relief Packages; Healthcare Access/Privacy.
H.R.1384 - 116th Congress (2019-2020)
Medicare for All Act of 2019
Sponsor: Rep. Jayapal, Pramila [D-WA-7] (Introduced 02/27/2019)
H.R.1520 - 116th Congress (2019-2020)
Purple Book Continuity Act of 2019
Sponsor: Rep. Eshoo, Anna G. [D-CA-18] (Introduced 03/05/2019)
S.1895 - 116th Congress (2019-2020)
Lower Health Care Costs Act
Sponsor: Sen. Alexander, Lamar [R-TN] (Introduced 06/19/2019)
H.R.1046 - 116th Congress (2019-2020)
Medicare Negotiation and Competitive Licensing Act of 2019
Sponsor: Rep. Doggett, Lloyd [D-TX-35]
H.R. 3630 - 116th Congress (2019-2020)
No Surprises Act
Rep. Frank Pallone Jr. (D-NJ-6)
H.R. 3439 - 116th Congress (2019-2020)
PATIENT Act
Rep. Donald S. Beyer, Jr. (D-VA-8)
H.R. 3107 - 116th Congress (2019-2020)
Improving Seniors Timely Access to Care Act of 2019
Rep. Suzane K. DelBene (D-WA-1)
H.R. 2279 - 116th Congress (2019-2020)
Safe Step Act
Rep. Raul Ruiz (D-CA-36)
S. 1895- 116th Congress (2019-2020)
Lower Health Care Costs Act
Sen. Lamar Alexander (R-TN)
S. 2456 - 116th Congress (2019-2020)
Safe Step Act
Sen. Lisa Murkowski (R-AK)
S. 2004 - 116th Congress (2019-2020)
Ensuring FEDVIP and FLTCIP Coverage During Shutdown Act
Rep. Elijah Cummings (D-MD-07)
H.R. 2774 - 116th Congress (2019-2020)
Primary Care Patient Protection Act of 2019
Rep. Brad Schneider (D-IL-10)
H.R. 5826 - 116th Congress (2019-2020)
Consumer Protection Against Surpirse Medical Bills Act of 2020
Rep. Richard Neal (D-MA-01)
S. 3548 - 116th Congress Second Session
Coronavirus Aid, Relief and Economic Security Act
Sen. Mitch McConnell (R-KY)
H.R. 5575 - 116th Congress Second Session
Primary and Behavioral Health Care Access Act of 2020
Rep. Lauren Underwood (D-IL-14)
H.R. 5688 - 116th Congress Second Session
Reducing Administrative Costs and Burden in Health Care Act of 2020
Rep. Cindy Axne (D-IA-03)
HR 5763 - 116th Congress Second Session
National Telehealth Strategy and Data Advancement Act
Rep. Greg Gianforte (R-MT-At Large)
HR 5800 - 116th Congress Second Session
Ban Surprise Billing Act
Rep. Bobby Scott (D-VA-03)
HR 5807 - 116th Congress Second Session
Know Your Provider Act
Rep. John Larson (D-CT-01)
HR 5916 - 116th Congress Second Session
Transparent Health Care Pricing Act of 2020
Rep. Mike Gallagher (R-WI-08)
HR 6201 - 116th Congress Second Session
First Coronavirus Response Act
Rep. Nita Lowey (D-NY-17)
HR 6336 - 116th Congress Second Session
To amend title XI of the Social Security Act to provide for a waiver of payment reductions under the Medicare and Medicaid programs for certain nonapproved capital expenditures undertaken by health care facilities during the COVID-19 Emergency.
HR 6336 - 116th Congress Second Session
Care for COVID-19 Act
Rep. Paul Ruiz (D-CA-36)
HR 6299 - 116th Congress Second Session
Rapid Coverage of COVID-19 Vaccine Act of 2020
HR 5817 - 116th Congress Second Session
Fair and Honest Advance Cost Estimate for Patients Act of 2020
Rep. David Nunes (R-CA-22)
HR 5816 - 116th Congress Second Session
Continuing Care for Patients Act of 2020
Rep. Gwen Moore - (D-WI-4)
HR 5089 - 116th Congress Second Session
Better Information Act of 2020
Rep. Don Byer (D-VA-08)
HR 5826 - 116th Congress Second Session
Consumer Protections Against Surprise Medical Bills Act of 2020
Rep. Richard Neal (D-MA-01)
HR 6004 - 116th Congress Second Session
Transparency and Accountability in Health Care Costs and Prices Act of 2020
Rep. Dan Lipinski (D-IL-03)
HR 6005 - 116th Congress Second Session
Know the Price Act
Rep. Tom Malinowski (D-NJ-07)
HR 6132 - 116th Congress Second Session
Social Determinants for Moms Act of 2020
Rep. Lucy McBath (D-GA-06)
HR 6149 - 116th Congress Second Session
Medicaid Report on Expansion of Access to coverage for Health Act
REp. Joe Cunningham (D-SC-01)
HR 6151 - 116th Congress Second Session
CARING for Kids Act
Rep. Abby Finkenauer (D-IA-01)
HR 6173- 116th Congress Second Session
Covering Coronavirus Test Act of 2020
Rep. Diana DeGette (D-CO-01)
HR 6213 -116th Congress second Session
No Cost for COVID-19 testing Act
Rep. Fredrica Wilson (D-FL-24)
HR 6222 - 116th Congress Second Session
Ensuring Affordable COVID-19 Preventative Care Act of 2020
Rep. Jan Schakowsky (D-IL-09)
HR 6232 - 116th Congress Second Session
To Require the Secretary of Health and Human Services through the National Disaster Medical System, to provide for certain laboraty reimbursement for diagnostic testing for COVID-19 in uninsured individuals.
Rep. Tony Cardenas (D-CA-29)
HR 6231 - 116th Congress Second Session
Ensuring Access to COVID-19 Preventative Care Act of 2020
Rep. Larry Buschon (R-In-08)
HR 6244 - 116th Congress Second Session
To amend titles XVIII and XIX to provide for coverage at no cost sharing of COVID-19 testing under the Medicaid program and Children's Health Insurance Program.
Rep. Robin Kelly (D=IL-02)
HR 6263 - 116th Congress Second Session
To amend title XVII of the Social Security Act to Waive cost sharing under the Medicare program for certain visits relating to testing for COVID-19
Rep. John Sarbanes (D-MD-03)
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Amy |
Modlin |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
Medicare Advantage; Medicaid Rebates; Medicaid Expansion; Medicaid General; Rate Notice and Call Letter; Medicare Part D: NBPP, Part D Rx Rebates; Medicare Data Sharing Privacy Medicare prescription drug prices; CMS Program Integrity Rule, Generic Drugs (CREATES) drug approval; Help cost reduction package, CHIP, MACRA Provider funding.
H.R.3 - 116th Congress (2019-2020)
Lower Drug Costs Now Act of 2019
Sponsor: Rep. Pallone, Frank, Jr. [D-NJ-6]
H.R.275 - 116th Congress (2019-2020)
Medicare Prescription Drug Price Negotiation Act of 2019
Sponsor: Rep. Welch, Peter [D-VT-At Large]
H.R.448 - 116th Congress (2019-2020)
Medicare Drug Price Negotiation Act
Sponsor: Rep. Cummings, Elijah E. [D-MD-7]
H.R.1046 - 116th Congress (2019-2020)
Medicare Negotiation and Competitive Licensing Act of 2019
Sponsor: Rep. Doggett, Lloyd [D-TX-35]
H.R.4629 - 116th Congress (2019-2020)
Star Rating for Biosimilars Act
Sponsor: Rep. Tonko, Paul [D-NY-20]
H.R. 3107 - 116th Congress
Improving Seniors' Timely Access to Care Act of 2019
Rep. Suzan DelBene (D-WA-01)
HR 4996 - 116th Congress First Session
Helping MOMS Act of 2019
Rep. Robin Kelly (D-IL-02)
HR 5882 - 116th Congress - Second Session
Parental Accessibility Rights for Emergency and Negligent Treatment Act
Rep. Greg Murphy (R=NC-03)
HR 5741 - 116th Congress Second Session
Strengthening Innovation in Medicare and Medicaid Act
Rep. Terri Sewell (D-AL-07)
HR 5900 - 116th Congress Second Session
Accelerating Kids' Access to Care Act
Rep. Joe Kennedy III (D-MA-04)
HR 6098 - 116th Congress Second Session
To amend title XXI of the Social Security Act to allow States to expand income eligibility standards under the Children's Health Insurance Program, and for other purposes.
Rep. Nanette Barragan (D-CA-44)
HR 6273 - 116th Congress Second Session
Protecting Vulnerable Americans in Times of Crisis Act of 2020
Rep. GK Butterfield (D-NC-01)
HR 5693 - 116th Congress Second Session
Primary Health Services Enhancement Act
Rep. Ron Kind (D-WI-03)
HR 6147 - 116th Congress Second Session
Help Extend Auditory Relieve (HEAR) Act of 2020
Rep. Matt Cartwright (D-PA-08)
HR 6179 - 116th Congress Second Session
Increasing Access to Biosimilars Act of 2020
Rep Tony Cardenas (D-Ca-29)
HR 6218 - 116th Congress Second Session
Preserving Patient Access to Home Infusion Act
Rep. Eliot Engel (D-NY-16)
HR 5534 - 116th Congress Second Session
Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2019
Rep. Ron Kind (D-WI-03)
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Amy |
Modlin |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TAX
16. Specific lobbying issues
Health Insurance Tax (HIT Tax); Health Reimbursement Arrangements (HRA's); Tax Extenders
H.R.748 - 116th Congress (2019-2020)
Middle Class Health Benefits Tax Repeal Act of 2019
Sponsor: Rep. Courtney, Joe [D-CT-2]
H.R.1398 - 116th Congress (2019-2020)
Health Insurance Tax Relief Act of 2019
Sponsor: Rep. Bera, Ami [D-CA-7] (Introduced 02/27/2019)
HR 3107 - 116th Congress (2019-2020)
Improving Seniors' Timely Access to Care Act of 2019
Rep. Suzan DelBene (D-WA-01)
HR 2774 - 116th Congress First Session
Primary Care Patient Protection Act of 2019
Rep. Brad Schneider (D-IL-10)
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Amy |
Modlin |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code PHA
16. Specific lobbying issues
Opioids (Epidemic, Deterrence, Economic Impact Zones); CREATES Act; Drug Pricing; PBM/Prescription Drug Costs Rx Rebates; Direct-to-Consumer Rx Advertising;Rx Rebates; Biosimilars; Drug approval; Drug patents, generic drugs, Part D Reform, Biosimilars, Civica RX
H.R. 938 - 116th Congress (2019-2020)
BLOCKING Act of 2019
Sponsor: Rep. Schrader, Kurt (D-OR-5)
H.R.1520 - 116th Congress (2019-2020)
Purple Book Continuity Act of 2019
Sponsor: Rep. Eshoo, Anna G. [D-CA-18]
H.R.1503 - 116th Congress (2019-2020)
Orange Book Transparency Act of 2019
Sponsor: Rep. Kelly, Robin L. [D-IL-2]
H.R.1499 - 116th Congress (2019-2020)
Protecting Consumer Access to Generic Drugs Act of 2019
Sponsor: Rep. Rush, Bobby L. [D-IL-1]
H.R.965 - 116th Congress (2019-2020)
CREATES Act of 2019
Sponsor: Rep. Cicilline, David N. [D-RI-1]
H.R.3 - 116th Congress (2019-2020)
Lower Drug Costs Now Act of 2019
Sponsor: Rep. Pallone, Frank, Jr. [D-NJ-6]
H.R.275 - 116th Congress (2019-2020)
Medicare Prescription Drug Price Negotiation Act of 2019
Sponsor: Rep. Welch, Peter [D-VT-At Large]
H.R.448 - 116th Congress (2019-2020)
Medicare Drug Price Negotiation Act
Sponsor: Rep. Cummings, Elijah E. [D-MD-7]
S. 3902 - 116th Congress (2019-2020)
Expanding Access to Low Cost Generics act of 2019
Sponsor: Sen. Tina Smith (D-MN)
HR 1046 - 116th Congress (2019-2020)
Medicare Negotiation and Competitive Licensing Act of 2019
Sponsor: Rep. Doggett, Lloyd (D-TX-35)
S. 2546 - 116th Congress (2019-2020)
Safe Step Act
Sen. Lisa Murkowski (R-AK)
H.R. 19 - 116th Congress First Session
Lower Costs, More Cures Act of 2019
Rep. Greg Walden (R-OR-02)
H.R. 5691 - 116th Congress Second Session
Insulin Affordability Data Collection Act
H.R. 5894 - 116th Congress Second Session
Transparency in Prescription Drug Advertising Act
Rep. Sharice Davids (D-KS-03)
H.R. 5927 - 116th Congress Second Session
Safe Medicine Act
Rep. Bill Posey (R-FL-08)
H.R. 5663 - 116th Congress Second Session
Safeguarding Theraputics Act
Rep. Brett Guthrie (R-KY-2)
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Amy |
Modlin |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code GOV
16. Specific lobbying issues
OPM Reorganization
HR 2003 - 116th Congress (2019-2020)
Ensuring FEHPB Coverage during Shutdown Act
Rep. Elijah E. Cummings
S. 971 - 116th Congress (2019-2020)
Ensuring FEHBP Coverage During Shutdown Act
Sen. Tina Smith (D-MN)
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Amy |
Modlin |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
| Address |
|
||||||
| City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
| City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
| 1 |
|
3 |
|
||||||
| 2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
| Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
||||||||||||||
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
| 1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
| Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% | |||||||||||||
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
| 1 | 3 | 5 |
| 2 | 4 | 6 |
CONVICTIONS DISCLOSURE
29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
| Lobbyist Name | Description of Offense(s) |